Skip to content

The Effect of Remifentanil on Rebound Pain

The Effect of Remifentanil on Rebound Pain in Patients Receiving General Anesthesia for Shoulder Arthroplasty After Brachial Plexus Block for Postoperative Pain Control

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04236323
Enrollment
68
Registered
2020-01-22
Start date
2020-02-14
Completion date
2021-01-07
Last updated
2021-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Keywords

hyperalgesia, brachial plexus block, remifentanil

Brief summary

The investigators will evaluate the influence of intraoperative remifentanil infusion on the postoperative hyperalgesia in patients receiving rotator cuff repair after brachial plexus block for postoperative analgesia.

Detailed description

The study will include 68 patients undergoing rotator cuff repair. All patients will receive brachial plexus block for postoperative analgesia, followed by general anesthesia. In the experimental group, remifentanil infusion will not be used intraoperatively, and in the control group, remifentanil will be infused. After surgery, both groups will be given the same postoperative pain management using patient controlled analgesia(PCA), and pain patterns will be assessed using the Numerical rating scale (NRS) at 4 hour intervals for 24 hours. The primary end point of this study is the total dose of PCA medication over 24 hours.

Interventions

DRUGNot used remifentanil infusion

Remifentanil is not used during operation

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA class I,II,III * Patients undergoing arthroscopic rotator cuff repair surgery under general anesthesia after interscalen brachial plexus block for post operative analgesia * Age ranges from 20 to 70

Exclusion criteria

* Patients who didn't agree to study * Patients can't control PCA(Patient-Controlled-Analgesia) independently * Patients who have conciousness disorder or can't express their pain level by NRS(Numeric Rating Scale) system * Patients who have severe respiratory disease or hepatic failure * Patinets who have known neuropathy or coagulopathy * Pregnancy * Patients with allegies to the drugs used in this study

Design outcomes

Primary

MeasureTime frameDescription
Total infused dose of patient controlled analgesia(PCA) drug during 24 hoursFrom end of operation to the 24hours after operationTotal infused dose of patient controlled analgesia(PCA) drug during first 24 hours after rotor cuff repair under general anesthesia

Secondary

MeasureTime frameDescription
Numerical Ratings ScalePain levels are checked using Numerical Ratings Scale at 4 hour intervals for 24 hours after surgeryDegree of pain is assessed using Numerical Ratings Scale at 4 hours for 24 hours after operation. The patients choose one of the digits from 0 to 10, the zero-point is painless, and the ten-point means the one with the most severe pain.
Total patient's trial to PCA bolus infusion24 hours after surgeryThe total number of times patients press the infusion button on the PCA to control pain
Incidence of postoperative nausea and vomiting24 hours after surgeryPostoperative nausea and vomiting is assessed at 24hr after surgery by a face-to face interview

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026